Document Detail


Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease.
MedLine Citation:
PMID:  11505078     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute myocardial infarction (AMI) is more frequent in winter months than in summer months. The aetiologic mechanisms underlying this seasonal pattern are poorly understood. We investigate whether seasonal variation of metabolic and haemostatic coronary risk factors exists, and whether this variation is more pronounced in subjects with coronary artery disease (CAD). In 82 subjects (47 free of clinical signs of CAD and in 35 survivors of AMI), measurements of body mass index (BMI), lipoproteins, glucose, insulin, plasminogen activator inhibitor-1, tissue-type plasminogen activator (t-PA), euglobulin clot lysis time, fibrinogen, and platelet count were performed twice in the cold months (December and March) and twice in the warm months (June and September). Significantly higher BMI (26.8 versus 26.2 kg/m2, P < 0.01), glucose (5.5 versus 5.1 mmol/l, P < 0.01), total cholesterol (5.61 versus 5.32 mmol/l, P < 0.05), low-density lipoprotein cholesterol (3.63 versus 3.34 mmol/l, P < 0.05), triglycerides (1.79 versus 1.61 mmol/l, P < 0.01), Lp(a) (270.7 versus 237.5 mg/l, P < 0.01), fibrinogen level (3.50 versus 2.95 g/l, P < 0.00001), platelet count (212 x 10(9) versus 173 x 10(9)/l, P < 0.01) and significantly lower high-density lipoprotein cholesterol level (1.22 versus 1.28 mmol/l, P < 0.05) were observed in the cold months compared with the warm months. Significant seasonal variation of t-PA activity (1.19 versus 0.87 IU/ml, P = 0.015) and t-PA antigen (8.5 versus 7.3 ng/ml, P = 0.05) was demonstrated only in subjects with CAD. Clustering of peak values of several metabolic and haemostatic coronary risk factors was observed in winter months. This variation might be of aetiopathogenetic importance for the seasonal pattern of acute myocardial infarction.
Authors:
A Mavri; B Guzic-Salobir; B Salobir-Pajnic; I Keber; J Stare; M Stegnar
Related Documents :
10559508 - Hmg coa reductase inhibitors are related to improved systemic endothelial function in c...
3698268 - Association of apolipoprotein e polymorphism, low-density lipoprotein cholesterol, and ...
2668448 - Coronary heart disease in south asians overseas: a review.
11084668 - Acute myocardial infarction in a 34-year-old hiv-positive female patient while undergoi...
21200318 - Unrecognized myocardial scars detected by delayed-enhanced mri are associated with incr...
8901478 - Hsp25 in isolated perfused rat hearts: localization and response to hyperthermia.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  12     ISSN:  0957-5235     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2001 Jul 
Date Detail:
Created Date:  2001-08-15     Completed Date:  2002-07-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  England    
Other Details:
Languages:  eng     Pagination:  359-65     Citation Subset:  IM    
Affiliation:
Department of Angiology, University Medical Centre, Ljubljana, Slovenia. alenka.mavri@trnovo.kclj.si
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adult
Blood Coagulation Factors / metabolism
Blood Glucose / analysis
Body Mass Index
Case-Control Studies
Coronary Artery Disease / blood,  epidemiology,  etiology*
Female
Hemostatics / blood*
Humans
Lipids / blood
Male
Middle Aged
Risk Factors
Seasons*
Chemical
Reg. No./Substance:
0/Blood Coagulation Factors; 0/Blood Glucose; 0/Hemostatics; 0/Lipids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effects of danaparoid, dalteparin and heparin on tissue factor-induced experimental disseminated...
Next Document:  Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphobl...